217 related articles for article (PubMed ID: 7522379)
1. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
2. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
3. Rapid restoration of microcirculatory blood flow with hyperviscous and hyperoncotic solutions lowers the transfusion trigger in resuscitation from hemorrhagic shock.
Wettstein R; Erni D; Intaglietta M; Tsai AG
Shock; 2006 Jun; 25(6):641-6. PubMed ID: 16721273
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
5. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
[TBL] [Abstract][Full Text] [Related]
6. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
7. Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes.
Cabrales P; Tsai AG; Intaglietta M
Shock; 2007 Oct; 28(4):461-7. PubMed ID: 17558350
[TBL] [Abstract][Full Text] [Related]
8. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
[TBL] [Abstract][Full Text] [Related]
9. [Volume replacement solutions--pharmacology and clinical use].
Adams HA; Piepenbrock S; Hempelmann G
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jan; 33(1):2-17. PubMed ID: 9530478
[TBL] [Abstract][Full Text] [Related]
10. Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients.
Meyer P; Pernet P; Hejblum G; Baudel JL; Maury E; Offenstadt G; Guidet B
Acta Anaesthesiol Scand; 2008 Feb; 52(2):229-35. PubMed ID: 18034867
[TBL] [Abstract][Full Text] [Related]
11. [Blood volume replacement and hemodilution with hydroxyethyl starch].
Messmer K; Jesch F
Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
[TBL] [Abstract][Full Text] [Related]
12. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
13. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
Jung F; Waldhausen P; Spitzer S; Wenzel E
Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
Penner M; Fingerhut D; Tacke A
Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
[TBL] [Abstract][Full Text] [Related]
16. Changes in acid-base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children.
Sümpelmann R; Witt L; Brütt M; Osterkorn D; Koppert W; Osthaus WA
Paediatr Anaesth; 2010 Jan; 20(1):100-4. PubMed ID: 19968805
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experiences with a 6% hydroxyethyl starch 40000 solution; metabolic parameters and tolerance].
Kori-Lindner C; Hubert H
Infusionsther Klin Ernahr; 1978 Apr; 5(2):93-8. PubMed ID: 77256
[TBL] [Abstract][Full Text] [Related]
18. [Hydroxyethyl starch--an interim report].
Weidhase R; Faude K; Weidhase R
Anaesthesiol Reanim; 1998; 23(1):4-14. PubMed ID: 9553245
[TBL] [Abstract][Full Text] [Related]
19. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)].
Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyethyl starch: the effect of molecular weight and degree of substitution on intravascular retention in vivo.
Hitosugi T; Saito T; Suzuki S; Kubota I; Shoda E; Shimizu T; Oi Y
Anesth Analg; 2007 Sep; 105(3):724-8. PubMed ID: 17717230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
